Categories: Uncategorized

International Cancer Organizations Present Collaborative Work During Oncology Event in China

The National Comprehensive Cancer Network (NCCN) is honored to participate in the 4th International Congress of the Asian Oncology Society and the Chinese Congress on Holistic Integrative Oncology (2024 CCHIO).

XI’AN, China, Nov. 15, 2024 /PRNewswire/ — The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is taking part in the Fourth International Congress of the Asian Oncology Society and the Chinese Congress on Holistic Integrative Oncology (2024 CCHIO) sponsored by the China Anti-Cancer Association (CACA), Chinese Institute of Development Strategy on Holistic Integrative Medicine, and Asian Oncology Society (AOS). The three-day event highlights international collaborations to improve cancer treatment and outcomes across China and beyond.

“NCCN is honored to participate in this important meeting,” said Wui-Jin Koh, MD, Chief Medical Officer, NCCN. “China is one of the top three countries in the world in terms of number of registered users for our website and downloads of NCCN Guidelines. We are grateful that our evidence-based expert consensus-driven recommendations are being utilized to guide and improve care for people with cancer throughout China and all of Asia.”

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) help define and advance high-quality, high-value, patient-centered cancer care globally. There are 88 different NCCN Guidelines®, featuring recommendations from multi-disciplinary expert panels for treating nearly the vast majority of cancer types, plus screening, prevention, and supportive care. They are the most thorough and frequently updated clinical practice guidelines available in any area of medicine. NCCN Guidelines were downloaded more than 15 million times in 2023 worldwide, with nearly a million downloads from China alone.

- Advertisement -

NCCN has taken numerous strides in recent years to increase the global accessibility and relevance of NCCN Guidelines as a tool for helping people with cancer to live better lives. NCCN is pleased to collaborate with leading oncology groups in China, including:

  • Chinese Gynecologic Cancer Society (CGCS) and Shanghai Yanxin Cultural Firm
    • Through this ongoing collaboration, NCCN works with leading gynecologic experts in China to translate, adapt, and update NCCN Guidelines for Gynecologic Cancers, including Cervical Cancer, Gestational Trophoblastic Neoplasia, Ovarian Cancer, Uterine Neoplasms, and Vulvar Cancer.
  • Medlive

NCCN’s resources are available for free to people everywhere, including more than 100,000 registered users in China. NCCN Guidelines have been translated more than 250 times across approximately 50 languages, including 30 NCCN Guidelines in Chinese. The NCCN Global Program also provides free access to International Adaptations, NCCN Framework for Resource Stratification (NCCN Framework™), and NCCN Harmonized Guidelines™, which feature pragmatic approaches for defining appropriate treatment tailored to unique regional circumstances. Learn more and access all of these materials by visiting NCCN.org/global

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.

Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org

Logo – https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.com/in/news-releases/international-cancer-organizations-present-collaborative-work-during-oncology-event-in-china-302301665.html

Recent Posts

Augmentir Named 2024 Connected Worker Company of the Year by Frost & Sullivan

Augmentir's exceptional performance and contributions in the global ACW solutions space highlight its dedication to…

11 minutes ago

Bybit Waives P2P Transaction Fees for Users in Africa

DUBAI, UAE, Nov. 21, 2024 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume,…

11 minutes ago

GATORADE AND MANCHESTER CITY PLAYERS UNVEIL #THENOD AS AN UNSPOKEN SUPERPOWER IN FOOTBALL

Gatorade now has an official presence on the sidelines for both the UEFA Champions League and…

11 minutes ago

Gameloft for brands unveils COMBO! Core, a dedicated proposition for consumer brands to reach Gen Z and Millennials through non-intrusive in-game advertising

PARIS, Nov. 21, 2024 /PRNewswire/ -- Gameloft for brands, a leader in creating gamified advertising…

12 minutes ago

G-P Recognized as a Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500

G-P's placement on the list for the second consecutive year reflects continued investment in innovation…

12 minutes ago

Bybit Waives P2P Transaction Fees for Users in Africa

DUBAI, UAE, Nov. 21, 2024 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume,…

2 hours ago